SDI Collaborates with Fred Hutchinson Cancer Research Center to Discover Biomarkers for Use in Early Detection of Cancer
NEWARK, Del. & SEATTLE–(BUSINESS WIRE)–SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers. Initial studies will center on pancreatic cancer. SDI will provide the Hutchinson Center with approximately 1,000 antibodies for the collaborative studies from it
Read the original here:
SDI Collaborates with Fred Hutchinson Cancer Research Center to Discover Biomarkers for Use in Early Detection of Cancer


Comments
Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!